Intraoperative ultrasonography in patients undergoing surgery for Crohn's disease. Prospective evaluation of an innovative approach to optimize staging and treatment planning.


Journal

Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 11 12 2018
accepted: 22 06 2019
pubmed: 30 6 2019
medline: 28 1 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

Percutaneous ultrasonography (perc-US) and magnetic resonance enterography (e-MR) are the present standards for staging patients with Crohn's disease (CD). However, intraoperative data still have some discrepancies with preoperative ones. The contribution of intraoperative ultrasonography (IOUS) has never been evaluated. Sixty-five consecutive patients scheduled for ileal/colonic resection for CD between 2010 and 2014 were prospectively enrolled. All patients had perc-US, e-MR and IOUS. Data from different imaging modalities were compared. The reference standard was the final pathology. Surgery was scheduled because of intestinal obstruction (n = 31 patients), inflammatory mass (n = 21), fistula (n = 10), or abdominal pain/sepsis (n = 3). Fourteen (21.5%) patients had a major discrepancy between preoperative and intraoperative data that required a modification of the surgical planning (five additional ileal lesions, three unknown ileo-sigmoid fistulas, and six not confirmed CD sites). IOUS correctly staged CD in all but one patients (missed ileo-colonic fistula). Pathology data differed from Perc-US data in 13 (20%) patients, from e-MR data in 14 (21.5%), and from IOUS data in one (1.5%). The sensitivity of Perc-US, e-MR and IOUS was: for the identification of CD sites 84.2%, 86.1%, and 100%; for the identification of stenoses 86.8%, 86.8%, and 100%; for the identification of fistulas 75.0%, 81.3%, and 93.8%, respectively. IOUS contributed to the surgical planning in 8 (12.3%) patients. IOUS is a safe, feasible and easy-to-perform procedure that optimizes staging of CD and, in some patients, helps to better define the treatment strategy. It could be helpful to face complex disease presentations on the basis of objective and reproducible data.

Identifiants

pubmed: 31254233
doi: 10.1007/s13304-019-00668-7
pii: 10.1007/s13304-019-00668-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-312

Références

Ann Surg. 2000 Jan;231(1):38-45
pubmed: 10636100
Gut. 2001 Dec;49(6):777-82
pubmed: 11709511
Am J Gastroenterol. 2003 Jul;98(7):1545-55
pubmed: 12873576
Radiology. 2005 Jul;236(1):95-101
pubmed: 15987966
World J Gastroenterol. 2008 Jan 7;14(1):146-51
pubmed: 18176980
Radiology. 2008 Apr;247(1):64-79
pubmed: 18372465
Hepatogastroenterology. 1991 Feb;38(1):64-70
pubmed: 1851131
Scand J Gastroenterol. 2009;44(5):585-93
pubmed: 19148846
Radiology. 2009 Jun;251(3):751-61
pubmed: 19276325
Eur J Surg Oncol. 2010 Oct;36(10):941-8
pubmed: 20547445
Inflamm Bowel Dis. 2011 Apr;17(4):984-93
pubmed: 20722053
J Crohns Colitis. 2010 Feb;4(1):28-62
pubmed: 21122489
Inflamm Bowel Dis. 2011 May;17(5):1073-80
pubmed: 21484958
Inflamm Bowel Dis. 2011 May;17(5):1081-8
pubmed: 21484959
Aliment Pharmacol Ther. 2011 Jul;34(2):125-45
pubmed: 21615440
J Gastrointest Surg. 2012 Apr;16(4):806-14
pubmed: 22258869
Br J Surg. 2013 Mar;100(4):535-42
pubmed: 23339035
J Crohns Colitis. 2013 Aug;7(7):556-85
pubmed: 23583097
World J Surg. 2013 Nov;37(11):2655-63
pubmed: 23974959
Ann Surg Oncol. 2014 Apr;21(4):1276-86
pubmed: 24346766
Dis Colon Rectum. 2014 Dec;57(12):1364-70
pubmed: 25380001
BMJ Case Rep. 2015 Apr 22;2015:null
pubmed: 25903200
J Gastroenterol Hepatol. 2015 Dec;30(12):1713-9
pubmed: 26094852
J Ultrasound Med. 2015 Jul;34(7):1307-18
pubmed: 26112636
Surg Endosc. 2016 Mar;30(3):1212-8
pubmed: 26139492
Biomed Res Int. 2016;2016:3617179
pubmed: 27579309
Med Hypotheses. 2017 Jun;103:10-20
pubmed: 28571791
Scand J Gastroenterol. 2017 Oct;52(10):1086-1092
pubmed: 28622097
Dig Dis Sci. 1994 May;39(5):1126-33
pubmed: 8174427
Acad Emerg Med. 1996 Sep;3(9):895-900
pubmed: 8870764

Auteurs

Luca Viganò (L)

Division of Hepatobiliary and General Surgery, Department of Surgery, Humanitas Clinical and Research Center, IRCCS, Via Manzoni 56, 20089, Rozzano, Milan, Italy. luca.vigano@humanitas.it.
Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. luca.vigano@humanitas.it.

Michela Mineccia (M)

Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, Italy.

Franco Bertolino (F)

Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, Italy.
Department of General Surgery, Ospedale Savigliano ASL CN1, Savigliano, Italy.

Francesco Giraldi (F)

Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, Italy.

Caterina Rigazio (C)

Department of Gastroenterology, Ospedale Mauriziano Umberto I, Turin, Italy.

Rodolfo Rocca (R)

Department of Gastroenterology, Ospedale Mauriziano Umberto I, Turin, Italy.

Alessandro Ferrero (A)

Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH